Medicine
fromwww.scientificamerican.com
8 hours agoTrial of next-gen weight-loss drug retatrutide shows users lose almost a third of their body weight
Weekly retatrutide targets three gut hormone receptors and produced about 30% average body-weight loss over 80 weeks in phase III results.